Researchers Report That Thymosin Beta 4 Improves Neurological Function After Stroke (Medical News Today)

8 March 2010, 8:26 am

RegeneRx Biopharmaceuticals, Inc. (NYSE Alternext US:RGN) announced that a research team from the Henry Ford Hospital in Detroit, MI reported that Thymosin beta 4 (Tβ4), administered to rats one day after embolic stroke, improved neurological functional outcome compared to control animals. Improvement in neurological function was measured at various time intervals over a seven week period and ...... Read More »

More Topics from "News"

• National Hockey League Game Capsules (The Sports Network)
• SUV backs into MI school; six students injured (14 WFIE Evansville)
• 6 students injured when SUV backs into MI school (WAVE 3 Louisville)
• Man dead after killing MI officer, wounding another (WTOL 11 Toledo)
• The Crisis or Rising Health Care Costs Are Burdening Millions but There Are New Options Available to the Public for ... (Marketwire)
• News in Brief (Ile Camera)
• Ford, Google, Nokia, BMW, Mercedes-Benz, Audi, Volvo, GM, DOT & Yahoo! Converge in Detroit to Seize New Decade of ... (PRWeb via Yahoo! News)
• History buff studied Detroit transit (Detroit News)
• Flags at half-staff to honor fallen MI soldier (WZZM 13 Grand Rapids)